Neurology

Health & Wellness 4 min The Supplement Nicotinamide Riboside Did Not Slow Early Parkinson's in a Year-Long Trial In a 410-patient Norwegian trial, the NAD-raising compound brought no benefit, and patients did slightly worse... AM Amelia Wong 12 Oct Health & Wellness 3 min Tavapadon, a Parkinson's Drug Aimed at Different Dopamine Receptors, Wins FDA Approval AbbVie's Juvmo, tavapadon, is the first to target D1 and D5 receptors. It beat placebo in three trials but was... AM Amelia Wong 29 Sep